Travere Therapeutics Inc — Cash Flow (NASDAQ:TVTX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -42.74 M-14.79 M-186.29 M-280.02 M-237.47 M37.78 M 37.78 M Cash from investing activities -61.33 M-137.62 M-32.55 M55.78 M99.33 M27.89 M 27.89 M Cash from financing activities 127.71 M231.68 M117.57 M218.75 M139.42 M-33.47 M -33.47 M Free cash flow -67.31 M-38.94 M-214.85 M-322.28 M-273.69 M-20.37 M -20.51 M

Haberler

Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval (NASDAQ:TVTX)

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?

Stocks Rally on a Push for Diplomacy to End US-Iran War

Stifel, Filspari onayı sonrası Travere hedefini yükseltti

Stocks Rally on US-Iran Peace Hopes and Cooler PPI Growth

Stocks Climb on US-Iran Peace Talk Optimism and a Favorable PPI Report

Travere Therapeutics hissesi 42,2 dolarda 52 haftalık zirve yaptı

Travere Therapeutics Stock Skyrockets On Highly Anticipated FDA Approval

Cantor Fitzgerald, FSGS onayı sonrası Travere hisse notunu korudu

Guggenheim, Travere hisse hedefini FDA onayı sonrası 54 dolara yükseltti

H.C. Wainwright, FSGS onayı sonrası Travere hissesi için görüşünü korudu